Earlier this year, Truveris conducted an analysis that revealed prescription drug inflation of 10% in 2015, driven by an average price increase of 14.77% in branded pharmaceuticals. Martin Shkreli, the "Bad Boy of Pharma," received unwanted attention when his company Turing Pharmaceuticals purchased Daraprim and raised its price by approximately 5,500%. Hillary Clinton proposed to establish a federal task force to act as such in 2015.